Literature DB >> 7064472

Uncertainties in distinction of typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia.

S J Marx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7064472      PMCID： PMC1273556     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  12 in total

1.  Family studies in patients with primary parathyroid hyperplasia.

Authors:  S J Marx; A M Spiegel; E M Brown; G D Aurbach
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Familial benign hypercalcemia.

Authors:  T P Foley; H C Harrison; C D Arnaud; H E Harrison
Journal:  J Pediatr       Date:  1972-12       Impact factor: 4.406

3.  Neonatal primary hyperparathyroidism with autosomal dominant inheritance.

Authors:  A M Spiegel; H E Harrison; S J Marx; E M Brown; G D Aurbach
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

4.  Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.

Authors:  S J Marx; A M Spiegel; E M Brown; J O Koehler; D G Gardner; M F Brennan; G D Aurbach
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

5.  The parathyroid glands in familial hypocalciuric hypercalcemia.

Authors:  U Thorgeirsson; J Costa; S J Marx
Journal:  Hum Pathol       Date:  1981-03       Impact factor: 3.466

6.  Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.

Authors:  S J Marx; M F Attie; J L Stock; A M Spiegel; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1981-04       Impact factor: 5.958

7.  Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration.

Authors:  S J Marx; J L Stock; M F Attie; R W Downs; D G Gardner; E M Brown; A M Spiegel; J L Doppman; M F Brennan
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

8.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

9.  Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma.

Authors:  G Lönnerholm; T Foucard; B Lindström
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

10.  Primary hyperparathyroidism: changes in the pattern of clinical presentation.

Authors:  G R Mundy; D H Cove; R Fisken
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.